What are Biosimilar Therapies and Why Should We Care?

08/07/2018

Related Content

Weight Management
Weight Management
Tien Sy Dong, MD, PhD, on Microbiome Changes After Bariatric Surgery in Patients With NAFLD
11/13/2020
In this video, Tien Sy Dong, MD, PhD, from the University of California at Los Angeles, discusses his research on how bariatric surgery can alter the microbiome of certain patients with fatty liver disease...
11/13/2020
Endocrinology
Endocrinology
The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and CVD: An Analysis of the COMPASS Trial
07/02/2020
In this video, Deepak Bhatt, MD, MPH, highlights the findings from an analysis of the COMPASS trial that included patients with diabetes.
07/02/2020
Gastroenterology
Gastroenterology
What Factors Influence Choice of 1st Therapy in IBD: How Can We Predict Response & Be Smarter?
07/31/2018
07/31/2018
Hypertension
Ed Shahady and Louis Kuritzky
Hypertension
CRS 2013: Know Your Options: Pharmacologic and Nonpharmacologic Hypertension Management
10/22/2013
2013 Summit Co-Chair Edward Shahady, MD, FAACP, ABCL, interviews Louis Kuritzky, MD, on his live session presentation at the conference: "Know Your Options: Pharmacologic and Nonpharmacologic Hypertension...
10/22/2013
Cardiometabolic Risk
Cardiometabolic Risk
Dr. James Matera on Complex Hypertension and Cardiometabolic Risk
10/01/2018
Dr James Matera from CentraState Medical Center in Freehold, NJ, gives us an overview of his session from the 2018 Cardiometabolic Risk Summit in San Antonio, TX.
10/01/2018